Research Article
M Adams, C T Montague, J B Prins, J C Holder, S A Smith, L Sanders, J E Digby, C P Sewter, M A Lazar, V K Chatterjee, S O'Rahilly
Title and authors | Publication | Year |
---|---|---|
Rare variant associations with birth weight identify genes involved in adipose tissue regulation, placental function and insulin-like growth factor signalling
Kentistou KA, Lim BE, Kaisinger LR, Steinthorsdottir V, Sharp LN, Patel KA, Tragante V, Hawkes G, Gardner EJ, Olafsdottir T, Wood AR, Zhao Y, Thorleifsson G, Day FR, Ozanne SE, Hattersley AT, O\u2019Rahilly S, Stefansson K, Ong KK, Beaumont RN, Perry JR, Freathy RM |
Nature Communications | 2025 |
Rare variant associations with birth weight identify genes involved in adipose tissue regulation, placental function and insulin-like growth factor signalling
Kentistou KA, Lim BE, Kaisinger LR, Steinthorsdottir V, Sharp LN, Patel KA, Tragante V, Hawkes G, Gardner EJ, Olafsdottir T, Wood AR, Zhao Y, Thorleifsson G, Day FR, Ozanne SE, Hattersley AT, O\u2019Rahilly S, Stefansson K, Ong KK, Beaumont RN, Perry JR, Freathy RM |
2024 | |
Associations between waist-to-height ratio and abdominal aortic calcification: A cross-sectional study
Sun L |
Medicine | 2024 |
Adipose Tissue Dysfunction Determines Lipotoxicity and Triggers the Metabolic Syndrome: Current Challenges and Clinical Perspectives.
Carobbio S, Pellegrinelli V, Vidal-Puig A |
Advances in experimental medicine and biology | 2024 |
Context-dependent regulation of lipid accumulation in adipocytes by a HIF1alpha-PPARgamma feedback network
Kudo T, Zhao ML, Jeknić S, Kovary K, LaGory EL, Covert MW, Teruel MN |
Cell Systems | 2023 |
Neohesperidin Dihydrochalcone and Neohesperidin Dihydrochalcone-O-Glycoside Attenuate Subcutaneous Fat and Lipid Accumulation by Regulating PI3K/AKT/mTOR Pathway In Vivo and In Vitro
M Kwon, Y Kim, J Lee, J Manthey, Y Kim, Y Kim |
Nutrients | 2022 |
State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions
Lavin KM, Coen PM, Baptista LC, Bell MB, Drummer D, Harper SA, Lixandrão ME, McAdam JS, O\u2019Bryan SM, Ramos S, Roberts LM, Vega RB, Goodpaster BH, Bamman MM, Buford TW |
Comprehensive Physiology | 2022 |
Enhanced C/EBPβ function promotes hypertrophic versus hyperplastic fat tissue growth and prevents steatosis in response to high-fat diet feeding.
Müller C, Zidek LM, Eichwald S, Kortman G, Koster MH, Calkhoven CF |
eLife | 2022 |
Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility
Przybycień P, Gąsior-Perczak D, Placha W |
Cells | 2022 |
Physiological Systems in Promoting Frailty
Perazza LR, Brown-Borg HM, Thompson LV |
Comprehensive Physiology | 2022 |
Contribution of markers of adiposopathy and adipose cell size in predicting insulin resistance in women of varying age and adiposity.
Tremblay EJ, Tchernof A, Pelletier M, Chabot N, Joanisse DR, Mauriège P |
Adipocyte | 2022 |
Genetic Evidence for Different Adiposity Phenotypes and Their Opposing Influences on Ectopic Fat and Risk of Cardiometabolic Disease
S Martin, M Cule, N Basty, J Tyrrell, RN Beaumont, AR Wood, TM Frayling, E Sorokin, B Whitcher, Y Liu, JD Bell, EL Thomas, H Yaghootkar |
Diabetes | 2021 |
Abdominal subcutaneous adipose tissue negatively associates with subclinical coronary artery disease in men with psoriasis
M Teklu, W Zhou, P Kapoor, N Patel, MP Playford, AV Sorokin, AK Dey, HL Teague, GA Manyak, JA Rodante, A Keel, MY Chen, DA Bluemke, AV Khera, NN Mehta |
2021 | |
Multi-omic Approaches to Identify Genetic Factors in Metabolic Syndrome
Clark KC, Kwitek AE |
Comprehensive Physiology | 2021 |
Novel PPARG mutation in multiple family members with chylomicronemia
M Glodowski, S Christen, DR Saxon, RA Hegele, RH Eckel |
Journal of Clinical Lipidology | 2021 |
Metabolomic Profiles in Adipocytes Differentiated from Adipose-Derived Stem Cells Following Exercise Training or High-Fat Diet
S Osawa, H Kato, Y Maeda, H Takakura, J Ogasawara, T Izawa |
International journal of molecular sciences | 2021 |
Associations of Visceral, Subcutaneous, Epicardial, and Liver Fat with Metabolic Disorders up to 14 Years After Weight Loss Surgery
SC Hunt, LE Davidson, TD Adams, L Ranson, RD McKinlay, SC Simper, SE Litwin |
Metabolic Syndrome and Related Disorders | 2021 |
Thiazolidinediones: An In–Depth Study of Their Synthesis and Application to Medicinal Chemistry in the Treatment of Diabetes Mellitus
N Long, AL Gresley, SP Wren |
ChemMedChem | 2021 |
Stroke Revisited: Diabetes in Stroke
SH Lee, DW Kang |
2021 | |
Impact of discontinuation of fish oil after pioglitazone–fish oil combination therapy in diabetic KK mice
Y Iizuka, K Chiba, H Kim, S Hirako, M Wada, A Matsumoto |
The Journal of Nutritional Biochemistry | 2020 |
Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease
A Chait, LJ den Hartigh |
Frontiers in Cardiovascular Medicine | 2020 |
Tributyltin disrupts fin development in Fundulus heteroclitus from both PCB-sensitive and resistant populations: Investigations of potential interactions between AHR and PPARγ
KA Crawford, BW Clark, WJ Heiger-Bernays, SI Karchner, ME Hahn, DE Nacci, JJ Schlezinger |
Aquatic toxicology (Amsterdam, Netherlands) | 2020 |
Bisphenol AF promotes inflammation in human white adipocytes
N Chernis, P Masschelin, AR Cox, SM Hartig |
American journal of physiology. Cell physiology | 2020 |
Glucagon-like Peptide-1: Actions and Influence on Pancreatic Hormone Function
Davis EM, Sandoval DA |
Comprehensive Physiology | 2020 |
Effect of Age and Lipoperoxidation in Rat and Human Adipose Tissue-Derived Stem Cells
MF Muñoz, S Argüelles, F Marotta, M Barbagallo, M Cano, A Ayala, JL Quiles |
Oxidative Medicine & Cellular Longevity | 2020 |
Depot-specific adipocyte-extracellular matrix metabolic crosstalk in murine obesity
C Strieder-Barboza, NA Baker, CG Flesher, M Karmakar, A Patel, CN Lumeng, RW ORourke |
Adipocyte | 2020 |
Hypolipidemic effects and mechanisms of Val-Phe-Val-Arg-Asn in C57BL/6J mice and 3T3-L1 cell models
X Zhang, W Shi, H He, R Cao, T Hou |
Journal of Functional Foods | 2020 |
Adipose-derived stromal/stem cells from different adipose depots in obesity development
KR Silva, LS Baptista |
World journal of stem cells | 2019 |
Adipogenesis and metabolic health.
Ghaben AL, Scherer PE |
Nature reviews. Molecular cell biology | 2019 |
Discovering metabolic disease gene interactions by correlated effects on cellular morphology
Y Jiao, U Ahmed, MF Sim, A Bejar, X Zhang, MM Talukder, R Rice, J Flannick, AI Podgornaia, DF Reilly, JM Engreitz, M Kost-Alimova, K Hartland, JM Mercader, S Georges, V Wagh, M Tadin-Strapps, JG Doench, JM Edwardson, JJ Rochford, ED Rosen, AR Majithia |
Molecular Metabolism | 2019 |
Adipogenesis and metabolic health
AL Ghaben, PE Scherer |
Nature Reviews Molecular Cell Biology | 2019 |
Metabolic Phenotyping of Adipose-Derived Stem Cells Reveals a Unique Signature and Intrinsic Differences between Fat Pads
C Lefevre, B Panthu, D Naville, S Guibert, C Pinteur, B Elena-Herrmann, H Vidal, GJ Rautureau, A Mey |
Stem Cells International | 2019 |
Peroxisome proliferator-activated receptor-γ gene polymorphism in psoriasis and its relation to obesity, metabolic syndrome, and narrowband ultraviolet B response: A case–control study in Egyptian patients
I Seleit, OA Bakry, EA Gayed, M Ghanem |
Indian journal of dermatology | 2019 |
Effect of PPAR-gamma agonist on aerobic exercise capacity in relation to body fat distribution in men with type 2 diabetes and coronary artery disease
M Bastien, P Poirier, P Brassard, BJ Arsenault, OF Bertrand, JP Després, O Costerousse, ME Piche |
American journal of physiology. Endocrinology and metabolism | 2019 |
De novo adipocyte differentiation from Pdgfrβ+ preadipocytes protects against pathologic visceral adipose expansion in obesity
M Shao, L Vishvanath, NC Busbuso, C Hepler, B Shan, AX Sharma, S Chen, X Yu, YA An, Y Zhu, WL Holland, RK Gupta |
Nature Communications | 2018 |
Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches
A Vallée, Y Lecarpentier, R Guillevin, JN Vallée |
International journal of molecular sciences | 2018 |
Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment
E Bonora, R DeFronzo |
2018 | |
Adipose cell size: importance in health and disease
KG Stenkula, C Erlanson-Albertsson |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2018 |
The role of adipose tissue in cardiovascular health and disease
EK Oikonomou, C Antoniades |
Nature Reviews Cardiology | 2018 |
Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment
E Bonora, RA DeFronzo |
2018 | |
Obesity and Lipotoxicity
AB Engin, A Engin |
Obesity and Lipotoxicity | 2017 |
Interplay between the renin-angiotensin system, the canonical WNT/β-catenin pathway and PPARγ in hypertension
A Vallée, BL Lévy, J Blacher |
Current Hypertension Reports | 2017 |
Adipose tissue macrophages impair preadipocyte differentiation in humans
LF Liu, CM Craig, LL Tolentino, O Choi, J Morton, H Rivas, SW Cushman, EG Engleman, T McLaughlin, F Giorgino |
PloS one | 2017 |
Depot-specific differences in fat mass expansion in WT and ob/ob mice
X Wang, C Yu, J Feng, J Chen, Q Jiang, S Kuang, Y Wang |
Oncotarget | 2017 |
PPAR γ and Its Role in Cardiovascular Diseases
M Chandra, S Miriyala, M Panchatcharam |
PPAR Research | 2017 |
PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation: PPARs in the CNS and neurodegenerative diseases
JM Zolezzi, MJ Santos, S Bastías-Candia, C Pinto, JA Godoy, NC Inestrosa |
Biological Reviews | 2017 |
PPAR γ and Its Role in Cardiovascular Diseases
M Chandra, S Miriyala, M Panchatcharam |
PPAR Research | 2017 |
La tormentosa relación entre las grasas y el desarrollo de la diabetes mellitus de tipo 2: actualizado. Parte 1
JE Gil, E Spinedi |
Revista Argentina de Endocrinología y Metabolismo | 2017 |
From chronic overnutrition to metaflammation and insulin resistance: adipose tissue and liver contributions
T Caputo, F Gilardi, B Desvergne |
FEBS Letters | 2017 |
Proliferation, Metabolic Activity, and Adipogenic Differentiation of Human Preadipocytes Exposed to 2 Surfactants In Vitro
T Ruhl, G Storti, N Pallua |
Journal of Pharmaceutical Sciences | 2017 |
PPARγ signaling and emerging opportunities for improved therapeutics
S Wang, EJ Dougherty, RL Danner |
Pharmacological Research | 2016 |
Endocrinology: Adult and Pediatric
M Gurnell, TJ Visser, P Beck-Peccoz, VK Chatterjee |
Endocrinology: Adult and Pediatric | 2016 |
Effects of fish oil supplementation and supplementation period on adipose tissue generation sites and the gene expression of enzymes involved in metabolizing adipose tissue in Holstein bulls under various forage types
HZ Bahnamiri, M Ganjkhanlou, M Sadeghi, MJ Najaf-panah, A Zali, W ZuYang |
Agri Gene | 2016 |
Endocrinology
C Napier, SH Pearce |
Endocrinology | 2016 |
BNIP3 is essential for mitochondrial bioenergetics during adipocyte remodelling in mice
JW Choi, A Jo, M Kim, HS Park, SS Chung, S Kang, KS Park |
Diabetologia | 2015 |
Control of Adipocyte Differentiation in Different Fat Depots; Implications for Pathophysiology or Therapy
X Ma, P Lee, DJ Chisholm, DE James |
Frontiers in Endocrinology | 2015 |
Effects of rosiglitazone on proliferation and differentiation of duck preadipocytes
F Ding, J Qiu, Q Li, J Hu, C Song, C Han, H He, J Wang |
In vitro cellular & developmental biology. Animal | 2015 |
Inhibitory effects of tannic acid in the early stage of 3T3-L1 preadipocytes differentiation by down-regulating PPARγ expression
F Nie, Y Liang, H Xun, J Sun, F He, X Ma |
Food & Function | 2015 |
Ethnic differences in pre-adipocyte intracellular lipid accumulation and alkaline phosphatase activity
AT Ali, G Chirambo, C Penny, JE Paiker, F Ikram, G Psaras, NJ Crowther |
Clinica Chimica Acta | 2015 |
MiR-378a-3p enhances adipogenesis by targeting mitogen-activated protein kinase 1
N Huang, J Wang, W Xie, Q Lyu, J Wu, J He, W Qiu, N Xu, Y Zhang |
Biochemical and Biophysical Research Communications | 2015 |
Expression of human and mouse adenine nucleotide translocase (ANT) isoform genes in adipogenesis
A Gavaldà-Navarro, P Domingo, O Viñas, T Mampel |
The International Journal of Biochemistry & Cell Biology | 2015 |
Gender differences in the hepatic elimination and pharmacokinetics of lobeglitazone in rats: Gender Difference of Lobeglitazone in Rats
JH Lee, JH Son, YJ Chae, SH Ahn, W Lee, DD Kim, SJ Chung |
Biopharmaceutics & Drug Disposition | 2015 |
Fat Removal: Invasive and Non-Invasive Body Contouring
SM Nasser, ZS Tannous |
Fat Removal: Invasive and Non-Invasive Body Contouring | 2015 |
International Textbook of Diabetes Mellitus: DeFronzo/International Textbook of Diabetes Mellitus, Fourth Edition
RN Bergman, M Ader |
International Textbook of Diabetes Mellitus: DeFronzo/International Textbook of Diabetes Mellitus, Fourth Edition | 2015 |
Mesoderm-specific transcript (MEST) is a negative regulator of human adipocyte differentiation
M Karbiener, C Glantschnig, DF Pisani, J Laurencikiene, I Dahlman, S Herzig, EZ Amri, M Scheideler |
International Journal of Obesity | 2015 |
Non-canonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion
JJ Fuster, MA Zuriaga, DT Ngo, MG Farb, T Aprahamian, TP Yamaguchi, N Gokce, K Walsh |
Diabetes | 2014 |
Lentiviral Delivery of PPARγ shRNA Alters the Balance of Osteogenesis and Adipogenesis, Improving Bone Microarchitecture
AW James, J Shen, K Khadarian, S Pang, G Chung, R Goyal, G Asatrian, O Velasco, J Kim, X Zhang, K Ting, C Soo |
Tissue Engineering Part A | 2014 |
Diabetes Mellitus and Human Health Care: A Holistic Approach to Diagnosis and Treatment
M Abhilash, R Augustine |
Diabetes Mellitus and Human Health Care: A Holistic Approach to Diagnosis and Treatment | 2014 |
Characteristic expression of extracellular matrix in subcutaneous adipose tissue development and adipogenesis; comparison with visceral adipose tissue
S Mori, S Kiuchi, A Ouchi, T Hase, T Murase |
International journal of biological sciences | 2014 |
Differentiation and characterization of human facial subcutaneous adipocytes
SH Chon, A Pappas |
Adipocyte | 2014 |
Fat depot-specific differences in pref-1 gene expression and adipocyte cellularity between Wagyu and Holstein cattle
T Yamada, M Higuchi, N Nakanishi |
Biochemical and Biophysical Research Communications | 2014 |
Glycyrrhizic Acid Can Attenuate Metabolic Deviations Caused by a High-Sucrose Diet without Causing Water Retention in Male Sprague-Dawley Rats
H Fernando, C Chandramouli, D Rosli, Y Lam, S Yong, H Yaw, S Ton, K Kadir, A Sainsbury |
Nutrients | 2014 |
Glypican 4 may be involved in the adipose tissue redistribution in high‑fat feeding C57BL/6J mice with peroxisome proliferators‑activated receptor�γ agonist rosiglitazone treatment
L Liu, H Gu, Y Zhao, L An, J Yang |
Experimental and therapeutic medicine | 2014 |
ISL1 Regulates Peroxisome Proliferator-Activated Receptor Activation and Early Adipogenesis via Bone Morphogenetic Protein 4-Dependent and -Independent Mechanisms
X Ma, P Yang, WH Kaplan, BH Lee, LE Wu, JY Yang, M Yasunaga, K Sato, DJ Chisholm, DE James |
Molecular and cellular biology | 2014 |
Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD
CD Fuchs, T Claudel, M Trauner |
Trends in Endocrinology & Metabolism | 2014 |
The Gut-Adipose-Liver Axis in the Metabolic Syndrome
D Konrad, S Wueest |
Physiology (Bethesda, Md.) | 2014 |
Lipids and Skin Health
A Pappas |
2014 | |
Expression Profiling of PPARγ-Regulated MicroRNAs in Human Subcutaneous and Visceral Adipogenesis in both Genders
J Yu, X Kong, J Liu, Y Lv, Y Sheng, S Lv, W Di, C Wang, F Zhang, G Ding |
Endocrinology | 2014 |
Adiposity and Insulin Resistance in Humans: The Role of the Different Tissue and Cellular Lipid Depots
S Hocking, D Samocha-Bonet, KL Milner, JR Greenfield, DJ Chisholm |
Endocrine reviews | 2013 |
Fyn deficiency promotes a preferential increase in subcutaneous adipose tissue mass and decreased visceral adipose tissue inflammation
TW Lee, H Kwon, H Zong, E Yamada, M Vatish, JE Pessin, CC Bastie |
Diabetes | 2013 |
Mechanisms and Metabolic Implications of Regional Differences among Fat Depots
T Tchkonia, T Thomou, Y Zhu, I Karagiannides, C Pothoulakis, MD Jensen, JL Kirkland |
Cell Metabolism | 2013 |
Macrophage-induced adipose tissue dysfunction and the preadipocyte: should I stay (and differentiate) or should I go?
A Sorisky, AS Molgat, AM Gagnon |
Advances in nutrition (Bethesda, Md.) | 2013 |
Review of Signaling Pathways Governing MSC Osteogenic and Adipogenic Differentiation
AW James |
Scientifica | 2013 |
Oral Green Tea Catechins Transiently Lower Plasma Glucose Concentrations in Female db/db Mice
S Wein, E Schrader, G Rimbach, S Wolffram |
Journal of Medicinal Food | 2013 |
Emery and Rimoin's Principles and Practice of Medical Genetics
DC Wallace, MT Lott, V Procaccio |
Emery and Rimoin's Principles and Practice of Medical Genetics | 2013 |
Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?
A Consoli, G Formoso |
Diabetes, Obesity and Metabolism | 2013 |
Pharmacologic agents for type 2 diabetes therapy and regulation of adipogenesis
A Cignarelli, F Giorgino, R Vettor |
Archives Of Physiology And Biochemistry | 2013 |
Efficacy and Safety of Adding Pioglitazone or Sitagliptin to Patients with Type 2 Diabetes Insufficiently Controlled with Metformin and a Sulfonylurea
SC Liu, KL Chien, CH Wang, WC Chen, CH Leung |
Endocrine Practice | 2013 |
Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trial
MJ Glesby, J Albu, YL Chiu, K Ham, E Engelson, Q He, V Muthukrishnan, HN Ginsberg, D Donovan, J Ernst, M Lesser, DP Kotler |
PloS one | 2013 |
Functional TRPV and TRPM channels in human preadipocytes
H Che, J Yue, HF Tse, GR Li |
Pflügers Archiv - European Journal of Physiology | 2013 |
Control of adipogenesis by the autocrine interplays between angiotensin 1-7/Mas receptor and angiotensin II/AT1 receptor signaling pathways
A Than, MK Leow, P Chen |
The Journal of biological chemistry | 2013 |
Daidzein regulates proinflammatory adipokines thereby improving obesity-related inflammation through PPARγ
Y Sakamoto, A Naka, N Ohara, K Kondo, K Iida |
Molecular Nutrition & Food Research | 2013 |
Effect of Pioglitazone on Production of Regulated upon Activation Normal T-cell Expressed and Secreted (RANTES) and IVF Outcomes in Infertile Women with Endometriosis
CH Kim, YJ Lee, JB Kim, KH Lee, SK Kwon, JW Ahn, SH Kim, HD Chae, BM Kang |
Development and Reproduction | 2013 |
Recombinant Human Growth Hormone and Rosiglitazone for Abdominal Fat Accumulation in HIV-Infected Patients with Insulin Resistance: A Randomized, Double-Blind, Placebo-Controlled, Factorial Trial
MJ Glesby, J Albu, YL Chiu, K Ham, E Engelson, Q He, V Muthukrishnan, HN Ginsberg, D Donovan, J Ernst, M Lesser, DP Kotler, J Ye |
PloS one | 2013 |
Control of Adipogenesis by the Autocrine Interplays between Angiotensin 1–7/Mas Receptor and Angiotensin II/AT 1 Receptor Signaling Pathways
A Than, MK Leow, P Chen |
The Journal of biological chemistry | 2013 |
Immunological Mechanisms and Therapies in Brain Injuries and Stroke
J Chen, X Hu, M Stenzel-Poore, JH Zhang |
2013 | |
Advances in Diagnosis and Management of Ovarian Cancer
SA Farghaly |
2013 | |
Obestatin regulates adipocyte function and protects against diet-induced insulin resistance and inflammation
R Granata, D Gallo, RM Luque, A Baragli, F Scarlatti, C Grande, I Gesmundo, J Córdoba-Chacón, L Bergandi, F Settanni, G Togliatto, M Volante, S Garetto, M Annunziata, B Chanclón, E Gargantini, S Rocchietto, L Matera, G Datta, M Morino, MF Brizzi, H Ong, G Camussi, JP Castaño, M Papotti, E Ghigo |
The FASEB Journal | 2012 |
Intrinsic differences in adipocyte precursor cells from different white fat depots
Y Macotela, B Emanuelli, MA Mori, S Gesta, TJ Schulz, YH Tseng, CR Kahn |
Diabetes | 2012 |
Peroxisome Proliferator-Activated Receptors (PPARs)
MZ Badr, JA Youssef |
Peroxisome Proliferator-Activated Receptors (PPARs) | 2012 |
Peroxisome Proliferator-Activated Receptors (PPARs)
MZ Badr, JA Youssef |
Peroxisome Proliferator-Activated Receptors (PPARs) | 2012 |
Peroxisome Proliferator-Activated Receptors (PPARs)
MZ Badr, JA Youssef |
Peroxisome Proliferator-Activated Receptors (PPARs) | 2012 |
Peroxisome Proliferator-Activated Receptors (PPARs)
MZ Badr, JA Youssef |
Peroxisome Proliferator-Activated Receptors (PPARs) | 2012 |
Peroxisome Proliferator-Activated Receptors (PPARs)
MZ Badr, JA Youssef |
Peroxisome Proliferator-Activated Receptors (PPARs) | 2012 |
PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty
JV Huang, CR Greyson, GG Schwartz |
Journal of lipid research | 2012 |
Mouse betaine-homocysteine S-methyltransferase deficiency reduces body fat via increasing energy expenditure and impairing lipid synthesis and enhancing glucose oxidation in white adipose tissue
YW Teng, JM Ellis, RA Coleman, SH Zeisel |
The Journal of biological chemistry | 2012 |
Seeking the source of adipocytes in adult white adipose tissues
YH Lee, JG Granneman |
Adipocyte | 2012 |
Plant Extracts of Winter Savory, Purple Coneflower, Buckwheat and Black Elder Activate PPAR-γ in COS-1 Cells but do not Lower Blood Glucose in Db/db Mice In vivo
E Schrader, S Wein, K Kristiansen, LP Christensen, G Rimbach, S Wolffram |
Plant Foods for Human Nutrition | 2012 |
Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy
P Zhao, Y Deng, P Gu, Y Wang, H Zhou, Y Hu, P Chen, X Fan |
Experimental Eye Research | 2012 |
Human adipose tissue stem cells: relevance in the pathophysiology of obesity and metabolic diseases and therapeutic applications
A Cignarelli, S Perrini, R Ficarella, A Peschechera, P Nigro, F Giorgino |
Expert Reviews in Molecular Medicine | 2012 |
Activation of peroxisome proliferator-activated receptor α (PPARα) suppresses hypoxia-inducible factor-1α (HIF-1α) signaling in cancer cells
J Zhou, S Zhang, J Xue, J Avery, J Wu, SE Lind, WQ Ding |
The Journal of biological chemistry | 2012 |
The effect of n-3 long chain fatty acids supplementation on plasma peroxisome proliferator activated receptor gamma and thyroid hormones in obesity
P Taraghijou, A Safaeiyan, M Mobasseri, A Ostadrahimi |
Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences | 2012 |
The Development of Subcutaneous Sarcomas in Rodents Exposed to Peroxisome Proliferators Agonists: Hypothetical Mechanisms of Action and De-Risking Attitude
IM Pruimboom-Brees, O Francone, JC Pettersen, RL Kerlin, Y Will, DE Amacher, GG Boucher, D Morton |
Toxicologic pathology | 2012 |
Mouse Betaine-Homocysteine S -Methyltransferase Deficiency Reduces Body Fat via Increasing Energy Expenditure and Impairing Lipid Synthesis and Enhancing Glucose Oxidation in White Adipose Tissue
YW Teng, JM Ellis, RA Coleman, SH Zeisel |
The Journal of biological chemistry | 2012 |
PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty: Thematic Review Series: New Lipid and Lipoprotein Targets for the Treatment of Cardiometabolic Diseases
JV Huang, CR Greyson, GG Schwartz |
Journal of lipid research | 2012 |
Static mechanical stretching accelerates lipid production in 3T3-L1 adipocytes by activating the MEK signaling pathway
N Shoham, R Gottlieb, O Sharabani-Yosef, U Zaretsky, D Benayahu, A Gefen |
American journal of physiology. Cell physiology | 2012 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Comprehensive Physiology
R Terjung |
Comprehensive Physiology | 2011 |
Diabetes - Perspectives in Drug Therapy
M Schwanstecher |
2011 | |
Diabetes - Perspectives in Drug Therapy
M Schwanstecher |
2011 | |
Diabetes - Perspectives in Drug Therapy
M Schwanstecher |
2011 | |
Diabetes - Perspectives in Drug Therapy
M Schwanstecher |
2011 | |
Diabetes - Perspectives in Drug Therapy
M Schwanstecher |
2011 | |
Diabetes - Perspectives in Drug Therapy
M Schwanstecher |
2011 | |
Diabetes - Perspectives in Drug Therapy
M Schwanstecher |
2011 | |
Diabetes - Perspectives in Drug Therapy
M Schwanstecher |
2011 | |
Diabetes - Perspectives in Drug Therapy
M Schwanstecher |
2011 | |
Diabetes - Perspectives in Drug Therapy
M Schwanstecher |
2011 | |
Diabetes - Perspectives in Drug Therapy
M Schwanstecher |
2011 | |
Diabetes - Perspectives in Drug Therapy
M Schwanstecher |
2011 | |
Diabetes - Perspectives in Drug Therapy
M Schwanstecher |
2011 | |
Diabetes - Perspectives in Drug Therapy
M Schwanstecher |
2011 | |
Cannabinoid type 1 receptor mediates depot-specific effects on differentiation, inflammation and oxidative metabolism in inguinal and epididymal white adipocytes
IV Wagner, N Perwitz, M Drenckhan, H Lehnert, J Klein |
Nutrition and Diabetes | 2011 |
In vivo adipogenesis in rats measured by cell kinetics in adipocytes and plastic-adherent stroma-vascular cells in response to high-fat diet and thiazolidinedione
YD Tchoukalova, M Fitch, PM Rogers, JD Covington, TM Henagan, J Ye, MK Hellerstein, E Ravussin |
Diabetes | 2011 |
Oxidative Stress and Disease
I Paur, M Carlsen, B Halvorsen, R Blomhoff |
Herbal Medicine | 2011 |
Type 2 Iodothyronine Deiodinase Is Expressed in Human Preadipocytes
E Nomura, N Toyoda, A Harada, K Nishimura, C Ukita, S Morimoto, A Kosaki, T Iwasaka, M Nishikawa |
Thyroid | 2011 |
The antihyperglycemic effect of curcumin in high fat diet fed rats. Role of TNF-α and free fatty acids
MA El-Moselhy, A Taye, SS Sharkawi, SF El-Sisi, AF Ahmed |
Food and Chemical Toxicology | 2011 |
Fat redistribution preferentially reflects the anti-inflammatory benefits of pioglitazone treatment
JH Moon, HJ Kim, SK Kim, ES Kang, BW Lee, CW Ahn, HC Lee, BS Cha |
Metabolism | 2011 |
Diabetes mellitus: new drugs for a new epidemic
G Nicholson, GM Hall |
British Journal of Anaesthesia | 2011 |
Determination of a peroxisome proliferator-activated receptor γ agonist, 1-(trans-methylimino-N-oxy)-6-(2-morpholinoethoxy-3-phenyl-1H-indene-2-carboxylic acid ethyl ester (KR-62980) in rat plasma by liquid chromatography–tandem mass spectrometry
MS Kim, JS Song, H Roh, JS Park, JH Ahn, SH Ahn, MA Bae |
Journal of Pharmaceutical and Biomedical Analysis | 2011 |
Annual Reports in Medicinal Chemistry
JJ Liu, TW Lee |
Annual Reports in Medicinal Chemistry Volume 46 | 2011 |
Stimulation of Glucose Uptake and Improvement of Insulin Resistance by Aromadendrin
WY Zhang, JJ Lee, IS Kim, Y Kim, CS Myung |
Pharmacology | 2011 |
Management of the metabolic effects of HIV and HIV drugs
TT Brown, MJ Glesby |
Nature reviews. Endocrinology | 2011 |
Metabolic syndrome: is the preadipocyte to blame?* : Commentary
A Rees |
Clinical Endocrinology | 2011 |
Dose-independent pharmacokinetics of a new peroxisome proliferator-activated receptor-γ agonist, KR-62980, in Sprague-Dawley rats and ICR mice
JS Park, MS Kim, JS Song, SH Choi, BH Lee, J Woo, JH Ahn, MA Bae, SH Ahn |
Archives of Pharmacal Research | 2011 |
Aging and Adipose Tissue
R Florido, T Tchkonia, JL Kirkland |
Handbook of the Biology of Aging | 2011 |
Proteomic characterization of adipose tissue constituents, a necessary step for understanding adipose tissue complexity
JR Peinado, M Pardo, O la Rosa, MM Malagón |
PROTEOMICS | 2011 |
Williams Textbook of Endocrinology
DW Cooke, SA Divall, S Radovick |
Williams Textbook of Endocrinology | 2011 |
The Actions of PPARγ Agonists on the Various Target Organs
JG Kang, CY Park |
The Korean Journal of Obesity | 2011 |
Fetal programming of adipose tissue: effects of intrauterine growth restriction and maternal obesity/high-fat diet
M Desai, MG Ross |
Seminars in reproductive medicine | 2011 |
Fetal Programming of Adipose Tissue: Effects of IUGR and Maternal Obesity/High Fat Diet
M Desai, MG Ross |
Seminars in reproductive medicine | 2011 |
Mast cells function as an alternative modulator of adipogenesis through 15-deoxy-delta-12, 14-prostaglandin J 2
A Tanaka, Y Nomura, A Matsuda, K Ohmori, H Matsuda |
American journal of physiology. Cell physiology | 2011 |
Endocrine Disruptors and Puberty
E Diamanti-Kandarakis, AC Gore |
2011 | |
Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery
EH Black, FA Nesi, CJ Calvano, GJ Gladstone, MR Levine |
2011 | |
Sex dimorphic actions of rosiglitazone in generalised peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-deficient mice
SZ Duan, MG Usher, EL 4th, DS Milstone, FC 3rd, RM Mortensen |
Diabetologia | 2010 |
Utility of transplantation in studying adipocyte biogenesis and function
Y Zhang |
Molecular and Cellular Endocrinology | 2010 |
Coordinate Transcriptomic and Metabolomic Effects of the Insulin Sensitizer Rosiglitazone on Fundamental Metabolic Pathways in Liver, Soleus Muscle, and Adipose Tissue in Diabetic db/db Mice
SL Bouter, M Rodriguez, N Guigal-Stephan, S Courtade-Gaïani, L Xuereb, C Montrion, V Croixmarie, T Umbdenstock, C Boursier-Neyret, M Lonchampt, M Brun, C Dacquet, A Ktorza, BP Lockhart, JP Galizzi |
PPAR Research | 2010 |
Immunopathogenesis of thyroid eye disease: emerging paradigms
VM Naik, MN Naik, RA Goldberg, TJ Smith, RS Douglas |
Survey of Ophthalmology | 2010 |
Coronary Heart Disease and Body Fat Distribution
D Canoy |
Current Atherosclerosis Reports | 2010 |
The many facets of PPARgamma: novel insights for the skeleton
M Kawai, KM Sousa, OA MacDougald, CJ Rosen |
American journal of physiology. Endocrinology and metabolism | 2010 |
The silencing mediator of retinoid and thyroid hormone receptors (SMRT) regulates adipose tissue accumulation and adipocyte insulin sensitivity in vivo
MM Sutanto, KK Ferguson, H Sakuma, H Ye, MJ Brady, RN Cohen |
The Journal of biological chemistry | 2010 |
Burger's Medicinal Chemistry and Drug Discovery
S Bruno, L Ronda, S Faggiano, S Bettati, A Mozzarelli |
Burger's Medicinal Chemistry and Drug Discovery | 2010 |
Adipose Depots Possess Unique Developmental Gene Signatures
Y Yamamoto, S Gesta, KY Lee, TT Tran, P Saadatirad, CR Kahn |
Obesity | 2010 |
Characteristics of Proliferation and Differentiation-Dependent C/EBP, PPARγ and Leptin Gene Expression Patterns Intrinsic to Bovine Intramuscular, Perirenal and Subcutaneous Preadipocytes
M Yamamoto, Y Taniguchi, K Kano, T Yamada |
Journal of Animal and Veterinary Advances | 2010 |
Series in Cosmetic and Laser Therapy
NE Rogers, MR Avram |
Hair Transplantation | 2010 |
Discovery and development of selective PPARγ modulators as safe and effective antidiabetic agents
LS Doshi, MK Brahma, UA Bahirat, AV Dixit, KV Nemmani |
Expert Opinion on Investigational Drugs | 2010 |
Selective effects of PPARγ agonists and antagonists on human pre-adipocyte differentiation
C Leyvraz, M Suter, C Verdumo, JM Calmes, A Paroz, C Darimont, RC Gaillard, FP Pralong, V Giusti |
Diabetes, Obesity and Metabolism | 2010 |
Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation
DP Schuster |
Diabetes, metabolic syndrome and obesity : targets and therapy | 2010 |
Site-specific modulation of white adipose tissue lipid metabolism by oleoyl-estrone and/or rosiglitazone in overweight rats
R Ferrer-Lorente, C Cabot, JA Fernández-López, M Alemany |
Naunyn-Schmiedeberg's Archives of Pharmacology | 2010 |
The HIV-1/HAART associated metabolic syndrome – Novel adipokines, molecular associations and therapeutic implications
S Tsiodras, A Perelas, C Wanke, CS Mantzoros |
Journal of Infection | 2010 |
Mannose-binding dietary lectins induce adipogenic differentiation of the marrow-derived mesenchymal cells via an active insulin-like signaling mechanism
M Bajaj, A Hinge, LS Limaye, RK Gupta, A Surolia, VP Kale |
Glycobiology | 2010 |
PPARγ regulates LIF-induced growth and self-renewal of mouse ES cells through Tyk2-Stat3 pathway
C Mo, W Chearwae, JJ Bright |
Cellular Signalling | 2010 |
Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal
A Tinelli, A Malvasi, G Leo, D Vergara, M Pisanò, M Ciccarese, VE Chiuri, V Lorusso |
Cancer and Metastasis Reviews | 2010 |
Mechanisms of adipose tissue redistribution with rosiglitazone treatment in various adipose depots
JG Kang, CY Park, SH Ihm, HJ Yoo, H Park, EJ Rhee, JC Won, WY Lee, KW Oh, SW Park, SW Kim |
Metabolism | 2010 |
Suppression of adipocyte differentiation by 15-methoxypinusolidic acid through inhibition of PPARγ activity
YS Lee, SH Sung, JH Hong, ES Hwang |
Archives of Pharmacal Research | 2010 |
The stromal-vascular fraction of adipose tissue contributes to major differences between subcutaneous and visceral fat depots
JR Peinado, Y Jimenez-Gomez, MR Pulido, M Ortega-Bellido, C Diaz-Lopez, FJ Padillo, J Lopez-Miranda, R Vazquez-Martínez, MM Malagón |
PROTEOMICS | 2010 |
Rosiglitazone increases cell surface GLUT4 levels in 3T3-L1 adipocytes through an enhancement of endosomal recycling
L Martinez, M Berenguer, MC Bruce, YL Marchand-Brustel, R Govers |
Biochemical Pharmacology | 2010 |
Adipose Tissue in Health and Disease: LEFF:ADIPOSE TISSUE O-BK
LA Cassis, SB Police |
Adipose Tissue in Health and Disease: LEFF:ADIPOSE TISSUE O-BK | 2010 |
Inhibitory effect and transcriptional impact of berberine and evodiamine on human white preadipocyte differentiation
Y Hu, H Fahmy, JK Zjawiony, GE Davies |
Fitoterapia | 2010 |
The Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT) Regulates Adipose Tissue Accumulation and Adipocyte Insulin Sensitivity in Vivo
MM Sutanto, KK Ferguson, H Sakuma, H Ye, MJ Brady, RN Cohen |
The Journal of biological chemistry | 2010 |
The many facets of PPARγ: novel insights for the skeleton
M Kawai, KM Sousa, OA MacDougald, CJ Rosen |
American journal of physiology. Endocrinology and metabolism | 2010 |
Obesity Before Birth
RH Lustig |
2010 | |
The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation
KM Wojtanik, K Edgemon, S Viswanadha, B Lindsey, M Haluzik, W Chen, G Poy, M Reitman, C Londos |
Journal of lipid research | 2009 |
Basic and Clinical Dermatology
N Muizzuddin, D Maes, P Giacomoni |
Skin Moisturization | 2009 |
Depot-Specific Differences in Adipogenic Progenitor Abundance and Proliferative Response to High-Fat Diet
AW Joe, L Yi, Y Even, AW Vogl, FM Rossi |
Stem Cells | 2009 |
Depot specificities of PPARγ ligand actions on lipid and glucose metabolism and their implication in PPARγ-mediated body fat redistribution
WT Festuccia, Y Deshaies |
Clinical Lipidology | 2009 |
Pioglitazone Increases the Proportion of Small Cells in Human Abdominal Subcutaneous Adipose Tissue
TM McLaughlin, T Liu, G Yee, F Abbasi, C Lamendola, GM Reaven, P Tsao, SW Cushman, A Sherman |
Obesity | 2009 |
Changes in physiology with increasing fat mass
DP Schuster |
Seminars in Pediatric Surgery | 2009 |
Regional variation in adipogenesis and IGF regulatory proteins in the fetal baboon
YD Tchoukalova, PW Nathanielsz, CA Conover, SR Smith, E Ravussin |
Biochemical and Biophysical Research Communications | 2009 |
Isohumulones, the bitter component of beer, improve hyperglycemia and decrease body fat in Japanese subjects with prediabetes
K Obara, M Mizutani, Y Hitomi, H Yajima, K Kondo |
Clinical Nutrition | 2009 |
Current Therapeutic Drugs for Type 2 Diabetes, Still Useful After 50 Years?
GM Hall, G Nicholson |
Anesthesia & Analgesia | 2009 |
Luteolin inhibits adipogenic differentiation by regulating PPARγ activation
HS Park, SH Kim, YS Kim, SY Ryu, JT Hwang, HJ Yang, GH Kim, DY Kwon, MS Kim |
BioFactors | 2009 |
Increased subcutaneous fat accumulation has a protective role against subclinical atherosclerosis in asymptomatic subjects undergoing general health screening
H Narumi, K Yoshida, N Hashimoto, I Umehara, N Funabashi, S Yoshida, I Komuro |
International Journal of Cardiology | 2009 |
Augmentation of PPARγ-TAZ interaction contributes to the anti-adipogenic activity of KR62980
H Jung, MS Lee, EJ Jang, JH Ahn, NS Kang, SE Yoo, MA Bae, JH Hong, ES Hwang |
Biochemical Pharmacology | 2009 |
PPARα signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells
ER Tuller, AL Brock, H Yu, JR Lou, DM Benbrook, WQ Ding |
Biochemical Pharmacology | 2009 |
Docosahexaenoic Acid Inhibits Superoxide Dismutase 1 Gene Transcription in Human Cancer Cells: The Involvement of Peroxisome Proliferator-Activated Receptor α and Hypoxia-Inducible Factor-2α Signaling
ER Tuller, CT Beavers, JR Lou, MA Ihnat, DM Benbrook, WQ Ding |
Molecular pharmacology | 2009 |
PPAR-gamma in the endothelium regulates metabolic responses to high fat diet
Takeshi Kanda, Jonathan D. Brown, Gabriela Orasanu, Silke Vogel, Juliano Sartoretto, Thomas Michel, Jorge Plutzky |
Journal of Clinical Investigation | 2008 |
It's not how fat you are, it's what you do with it that counts
S Virtue, A Vidal-Puig |
PLoS Biology | 2008 |
Distribution of body fat and risk of coronary heart disease in men and women
D Canoy |
Current Opinion in Cardiology | 2008 |
Role of Gender and Anatomical Region on Induction of Osteogenic Differentiation of Human Adipose-derived Stem Cells
AE Aksu, JP Rubin, JR Dudas, KG Marra |
Annals of Plastic Surgery | 2008 |
Regional Anatomic and Age Effects on Cell Function of Human Adipose-Derived Stem Cells
BM Schipper, KG Marra, W Zhang, AD Donnenberg, JP Rubin |
Annals of Plastic Surgery | 2008 |
Islet-1: A Potentially Important Role for an Islet Cell Gene in Visceral Fat
H Li, LK Heilbronn, D Hu, AM Poynten, MA Blackburn, DP Shirkhedkar, WH Kaplan, AD Kriketos, J Ye, DJ Chisholm |
Obesity | 2008 |
Pleiotropic effects of thiazolidinediones
CV Rizos, EN Liberopoulos, DP Mikhailidis, MS Elisaf |
Expert Opinion on Pharmacotherapy | 2008 |
Transcriptional Control of Mesenchymal Stem Cell Differentiation
J Frith, P Genever |
Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie | 2008 |
Peroxisome proliferator-activated receptor-gamma agonists and diabetes: current evidence and future perspectives
F Chiarelli, DD Marzio |
Vascular Health and Risk Management | 2008 |
Biological specificity of visceral adipose tissue and therapeutic intervention
S Perrini, A Leonardini, L Laviola, F Giorgino |
Archives Of Physiology And Biochemistry | 2008 |
Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus
HJ Kim, SK Kim, WS Shim, JH Lee, KY Hur, ES Kang, CW Ahn, SK Lim, HC Lee, BS Cha |
Diabetes Research and Clinical Practice | 2008 |
Pharmacogenomics of metabolic effects of rosiglitazone
O Šeda, L Šedová, O Oliyarnyk, L Kazdová, D Køenová, G Corbeil, P Hamet, J Tremblay, V Køen |
Pharmacogenomics | 2008 |
Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients
Y Miyazaki, RA DeFronzo |
Diabetes, Obesity and Metabolism | 2008 |
Transcriptional Control of Mesenchymal Stem Cell Differentiation
J Frith, P Genever |
Transfusion Medicine and Hemotherapy | 2008 |
Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients
A Brunani, A Caumo, S Graci, G Castagna, G Viberti, A Liuzzi |
Diabetes, Obesity and Metabolism | 2008 |
Subcutaneous Abdominal Adipose Tissue Subcompartments: Potential Role in Rosiglitazone Effects
GE Walker, P Marzullo, B Verti, G Guzzaloni, S Maestrini, F Zurleni, A Liuzzi, AM di Blasio |
Obesity | 2008 |
Effects of the Thiazolidinedione Medications on Micro- and Macrovascular Complications in Patients with Diabetes—Update 2008
A Rohatgi, DK McGuire |
Cardiovascular Drugs and Therapy | 2008 |
Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patients
YC Hwang, EY Lee, WJ Lee, BS Cha, KH Yoon, KS Park, MK Lee |
Metabolism | 2008 |
Adipocyte volumes and levels of adipokines in diabetes and obesity
D Gokalp, M Bahceci, S Ozmen, S Arikan, A Tuzcu, R Danıs |
Diabetes and Metabolic Syndrome Clinical Research and Reviews | 2008 |
Abdominal Obesity and the Endocannabinoid System: From Basic Aspects to Clinical Management of Related Cardiometabolic Risk
D Huffman, N Barzilai |
Abdominal Obesity and the Endocannabinoid System: From Basic Aspects to Clinical Management of Related Cardiometabolic Risk | 2008 |
How safe is the use of thiazolidinediones in clinical practice?
CV Rizos, M Elisaf, DP Mikhailidis, EN Liberopoulos |
Expert Opinion on Drug Safety | 2008 |
Peroxisome Proliferator-Activated Receptor γ as a Novel Therapeutic Target in Asthma
SJ Park, YC Lee |
Journal of Asthma | 2008 |
Optimization of in vitro conditions for bovine subcutaneous and intramuscular preadipocyte differentiation1
AC Grant, G Ortiz-Colòn, ME Doumit, DD Buskirk |
Journal of animal science | 2008 |
Differentiation of bovine intramuscular and subcutaneous stromal-vascular cells exposed to dexamethasone and troglitazone1
AC Grant, G Ortiz-Colón, ME Doumit, RJ Tempelman, DD Buskirk |
Journal of animal science | 2008 |
'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic Studies
M Gurnell |
PPAR Research | 2007 |
Vascular Peptide Endothelin-1 Links Fat Accumulation With Alterations of Visceral Adipocyte Lipolysis
V Harmelen, A Eriksson, G Astrom, K Wahlen, E Naslund, F Karpe, K Frayn, T Olsson, J Andersson, M Ryden, P Arner |
Diabetes | 2007 |
Aging in adipocytes: potential impact of inherent, depot-specific mechanisms
MJ Cartwright, T Tchkonia, JL Kirkland |
Experimental Gerontology | 2007 |
Effect of PPARalpha activation of macrophages on the secretion of inflammatory cytokines in cultured adipocytes
K Murakami, H Bujo, H Unoki, Y Saito |
European Journal of Pharmacology | 2007 |
Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer?
X Yang, U Smith |
Diabetologia | 2007 |
The importance of free fatty acids in the development of Type�2 diabetes
JP Wilding |
Diabetic Medicine | 2007 |
Fat Tissue
SM Niemel??, S Miettinen, Y Konttinen, T Waris, M Kellom??ki, NA Ashammakhi, T Ylikomi |
Journal of Craniofacial Surgery | 2007 |
COX-2 and SCD, Markers of Inflammation and Adipogenesis, Are Related to Disease Activity in Graves' Ophthalmopathy
T Vondrichova, A Capretz, H Parikh, C Frenander, P Åsman, M Åberg, L Groop, B Hallengren, M Lantz |
Thyroid | 2007 |
Pathogenesis of Graves' Ophthalmopathy: The Role of Autoantibodies
TK Khoo, RS Bahn |
Thyroid | 2007 |
Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model
HJ Kim, TW Jung, ES Kang, DJ Kim, CW Ahn, KW Lee, HC Lee, BS Cha |
Metabolism | 2007 |
Weight gain in type 2 diabetes mellitus
AN Jacob, K Salinas, B Adams-Huet, P Raskin |
Diabetes, Obesity and Metabolism | 2007 |
PPARs and the Placenta
T Fournier, V Tsatsaris, K Handschuh, D Evain-Brion |
Placenta | 2007 |
Reduced Adiposity in ob/ob Mice following Total Body Irradiation and Bone Marrow Transplantation*
V Ablamunits, SP Weisberg, JE Lemieux, TP Combs, S Klebanov |
Obesity | 2007 |
Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus
T Teranishi, T Ohara, K Maeda, M Zenibayashi, K Kouyama, Y Hirota, H Kawamitsu, M Fujii, K Sugimura, M Kasuga |
Metabolism | 2007 |
Antidiabetic medications in overweight/obese patients with type 2 diabetes: drawbacks of current drugs and potential advantages of incretin-based treatment on body weight
E Bonora |
International Journal of Clinical Practice | 2007 |
Hypertrophy and hyperplasia of abdominal adipose tissues in women
R Drolet, C Richard, AD Sniderman, J Mailloux, M Fortier, C Huot, C Rhéaume, A Tchernof |
International Journal of Obesity | 2007 |
Effects of pioglitazone on proliferation and differentiation of human preadipocytes
J Zhou, M Ge, Y Wang, H Wu, J Shen, X Ma |
Journal of Nanjing Medical University | 2007 |
Subcutaneous fat in normal and diseased states
MM Avram, AS Avram, WD James |
Journal of the American Academy of Dermatology | 2007 |
Hipertensión arterial y dislipemia asociadas a diabetes mellitus. Papel de los PPAR. Enfoque terapéutico
V Bertomeu-González, DN Pernas, VB Martínez |
Revista Española de Cardiología Suplementos | 2007 |
The increase in abdominal subcutaneous fat depot is an independent factor to determine the glycemic control after rosiglitazone treatment
SK Kim, KY Hur, HJ Kim, WS Shim, CW Ahn, SW Park, YW Cho, SK Lim, HC Lee, BS Cha |
European Journal of Endocrinology | 2007 |
Type 2 Diabetes: Principles and Practice, Second Edition
L Adams |
Type 2 Diabetes: Principles and Practice, Second Edition | 2007 |
Characterization of ScAP-23, a new cell line from murine subcutaneous adipose tissue, identifies genes for the molecular definition of preadipocytes
JY Kim, Y Wu, CM Smas |
Physiological genomics | 2007 |
Changes in liver PPARα mRNA expression in response to two levels of high-safflower-oil diets correlate with changes in adiposity and serum leptin in rats and mice
SC Hsu, C Huang |
The Journal of Nutritional Biochemistry | 2007 |
Pharmacotherapy of Diabetes: New Developments
CE Mogensen |
2007 | |
A Novel Inhibitory Protein in Adipose Tissue, the Aldo-Keto Reductase AKR1B7: Its Role in Adipogenesis
J Tirard, J Gout, AM Lefrançois-Martinez, A Martinez, M Begeot, D Naville |
Endocrinology | 2007 |
Thiazolidinediones and their Fluid-Related Adverse Effects: Facts, Fiction and Putative Management Strategies
J Karalliedde, RE Buckingham |
Drug Safety | 2007 |
Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns
T Tchkonia, M Lenburg, T Thomou, N Giorgadze, G Frampton, T Pirtskhalava, A Cartwright, M Cartwright, J Flanagan, I Karagiannides, N Gerry, RA Forse, Y Tchoukalova, MD Jensen, C Pothoulakis, JL Kirkland |
American journal of physiology. Endocrinology and metabolism | 2006 |
Peroxisome Proliferator-Activated Receptor γ and Adipose Tissue—Understanding Obesity-Related Changes in Regulation of Lipid and Glucose Metabolism
AM Sharma, B Staels |
The Journal of clinical endocrinology and metabolism | 2006 |
Rosiglitazone inhibits mouse liver regeneration
YP Turmelle, O Shikapwashya, S Tu, PW Hruz, Q Yan, DA Rudnick |
The FASEB Journal | 2006 |
Recombinant Methionyl Human Leptin Therapy in Replacement Doses Improves Insulin Resistance and Metabolic Profile in Patients with Lipoatrophy and Metabolic Syndrome Induced by the Highly Active Antiretroviral Therapy
JH Lee, JL Chan, E Sourlas, V Raptopoulos, CS Mantzoros |
The Journal of clinical endocrinology and metabolism | 2006 |
PPARγ and human metabolic disease
RK Semple, VK Chatterjee, S O'Rahilly |
Journal of Clinical Investigation | 2006 |
Macrophage-conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes
VA Constant, A Gagnon, A Landry, A Sorisky |
Diabetologia | 2006 |
Fat Depot-Specific Characteristics Are Retained in Strains Derived From Single Human Preadipocytes
T Tchkonia, N Giorgadze, T Pirtskhalava, T Thomou, M DePonte, A Koo, RA Forse, D Chinnappan, C Martin-Ruiz, T Zglinicki, JL Kirkland |
Diabetes | 2006 |
Mechanisms of the Depot Specificity of Peroxisome Proliferator-Activated Receptor Action on Adipose Tissue Metabolism
M Laplante, WT Festuccia, G Soucy, Y Gelinas, J Lalonde, JP Berger, Y Deshaies |
Diabetes | 2006 |
Insulin signalling in human adipose tissue
L Laviola, S Perrini, A Cignarelli, F Giorgino |
Archives Of Physiology And Biochemistry | 2006 |
Insulin Resistance and PPARγ
BS Cha, SE Park |
The Journal of Korean Diabetes Association | 2006 |
Evidence for a role of developmental genes in the origin of obesity and body fat distribution
S Gesta, M Blüher, Y Yamamoto, AW Norris, J Berndt, S Kralisch, J Boucher, C Lewis, CR Kahn |
Proceedings of the National Academy of Sciences | 2006 |
Pathogenesis of Graves Ophthalmopathy: Implications for Prediction, Prevention, and Treatment
JA Garrity, RS Bahn |
American Journal of Ophthalmology | 2006 |
Effect of troglitazone on tumor necrosis factor α and transforming growth factor β expression and action in human adipocyte precursor cells in primary culture
T Skurk, M Birgel, YM Lee, H Hauner |
Metabolism | 2006 |
15-Deoxy-Δ12,14-Prostaglandin J2 regulates leukemia inhibitory factor signaling through JAK-STAT pathway in mouse embryonic stem cells
J Rajasingh, JJ Bright |
Experimental Cell Research | 2006 |
Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
ME Risner, AM Saunders, JF Altman, GC Ormandy, S Craft, IM Foley, ME Zvartau-Hind, DA Hosford, AD Roses |
The Pharmacogenomics Journal | 2006 |
Acute and 1-month effect of small-volume suction lipectomy on insulin sensitivity and cardiovascular risk
DA Davis, DM Pellowski, DA Davis, WT Donahoo |
International Journal of Obesity | 2006 |
Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes
M Dorkhan, M Lantz, A Frid, L Groop, B Hallengren |
Clinical Endocrinology | 2006 |
Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial
G Umpierrez, M Issa, A Vlajnic |
Current Medical Research and Opinion | 2006 |
Long-term Effect of Pioglitazone Treatment in Patients with Type 2 Diabetes
JH Moon, HJ Kim, SK Kim, WS Shim, ES Kang, Y Rhee, CW Ahn, SK Lim, KR Kim, HC Lee, BS Cha |
The Journal of Korean Diabetes Association | 2006 |
Thiazolidinediones, insulin resistance and obesity: finding a balance
J Wilding |
International Journal of Clinical Practice | 2006 |
Depot-specific prostaglandin synthesis in human adipose tissue: A novel possible mechanism of adipogenesis
M Quinkler, IJ Bujalska, JW Tomlinson, DM Smith, PM Stewart |
Gene | 2006 |
The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells
K Goya, S Sumitani, M Otsuki, X Xu, H Yamamoto, S Kurebayashi, H Saito, H Kouhara, S Kasayama |
Journal of Diabetes and its Complications | 2006 |
The Emerging Functions of UCP2 in Health, Disease, and Therapeutics
G Mattiasson, PG Sullivan |
Antioxidants & Redox Signaling | 2006 |
The effects of irbesartan and telmisartan on metabolic parameters and blood pressure in obese, insulin resistant, hypertensive patients
R Negro, G Formoso, H Hassan |
Journal of Endocrinological Investigation | 2006 |
Thiazolidinediones and risk for atherosclerosis: pleiotropic effects of PPARγ agonism
CB Patle, JA de Lemos, KL Wyne, DK McGuire |
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease | 2006 |
The effects of telmisartan and amlodipine on metabolic parameters and blood pressure in type 2 diabetic, hypertensive patients
R Negro, H Hassan |
Journal of Renin-Angiotensin-Aldosterone System | 2006 |
Interleukin-6 release from human abdominal adipose cells is regulated by thyroid-stimulating hormone: effect of adipocyte differentiation and anatomic depot
TT Antunes, A Gagnon, B Chen, F Pacini, TJ Smith, A Sorisky |
American journal of physiology. Endocrinology and metabolism | 2006 |
Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK
B Molavi, J Chen, JL Mehta |
American journal of physiology. Heart and circulatory physiology | 2006 |
Characterization of the transcriptional and functional effects of fibroblast growth factor-1 on human preadipocyte differentiation
FS Newell, H Su, H Tornqvist, JP Whitehead, JB Prins, LJ Hutley |
The FASEB Journal | 2006 |
Long-Term Treatment with Lopinavir-Ritonavir Induces a Reduction in Peripheral Adipose Depots in Mice
M Prot, L Heripret, N Cardot-Leccia, C Perrin, M Aouadi, T Lavrut, R Garraffo, P Dellamonica, J Durant, YL Marchand-Brustel, B Binétruy |
Antimicrobial agents and chemotherapy | 2006 |
CYP450, COX-2 and Obesity Related Renal Damage
JD Imig, X Zhao, A Dey, M Shaw |
Toxicology Mechanisms and Methods | 2005 |
Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies
F Giorgino, L Laviola, JW Eriksson |
Acta Physiologica Scandinavica | 2005 |
Fatty acids and insulin resistance in muscle and liver
P Kovacs, M Stumvoll |
Best Practice & Research Clinical Endocrinology & Metabolism | 2005 |
Adiponectin receptor gene expression in human skeletal muscle cells is not regulated by fibrates and thiazolidinediones
S Kaltenbach, H Staiger, M Weisser, C Haas, M Stumvoll, F Machicao, HU Häring |
International Journal of Obesity | 2005 |
Evaluating the Cardiovascular Effects of the Thiazolidinediones and Their Place in the Management of Type 2 Diabetes in Relation to the Metabolic Syndrome
AJ Drexler, RW Nesto, MJ Abrahamson, G Bakris, D Bell, J Brunzell, P Dandona, J Davidson, V Fonseca, M Fowler, R Frye, T Giles, S Haffner, N Hollenberg, W Hsueh, R Law, J Plutzky, R Ratner, J Reusch, A Selwyn, J Sowers, K Wyne, LH Young |
Metabolic Syndrome and Related Disorders | 2005 |
Peroxisome proliferator-activated receptor γ and the regulation of adipocyte function: lessons from human genetic studies
M Gurnell |
Best Practice & Research Clinical Endocrinology & Metabolism | 2005 |
15d-PGJ2: The anti-inflammatory prostaglandin?
JU Scher, MH Pillinger |
Clinical Immunology | 2005 |
Rosiglitazone effects on blood pressure and metabolic parameters in nondipper diabetic patients
R Negro, T Mangieri, D Dazzi, A Pezzarossa, H Hassan |
Diabetes Research and Clinical Practice | 2005 |
Biology of Growing Animals
AW Bell, PL Greenwood, RA Ehrhardt |
Biology of Growing Animals | 2005 |
Rein et glitazones
G Deray, H Izzedine, V Launay-Vacher, C Bagnis |
Annales d'Endocrinologie | 2005 |
Données cliniques nouvelles sur les glitazones
B Guerci |
Annales d'Endocrinologie | 2005 |
Ácido linoléico conjugado e perda de peso
DM Mourão, JB Monteiro, PC Stringheta, VP Minim, CM Dias |
Revista de Microbiologia | 2005 |
Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots
T Tchkonia, YD Tchoukalova, N Giorgadze, T Pirtskhalava, I Karagiannides, RA Forse, A Koo, M Stevenson, D Chinnappan, A Cartwright, MD Jensen, JL Kirkland |
American journal of physiology. Endocrinology and metabolism | 2005 |
Predictors of improved glycaemic control with rosiglitazone therapy in type 2 diabetic patients: a practical approach for the primary care physician
Y Miyazaki, ED Filippis, M Bajaj, E Wajcberg, L Glass, C Triplitt, E Cersosimo, LJ Mandarino, RA Defronzo |
The British Journal of Diabetes & Vascular Disease | 2005 |
Cancer Chemoprevention
GJ Kelloff, ET Hawk, CC Sigman |
2005 | |
Fibroblast growth factor 1: a key regulator of human adipogenesis
L Hutley, W Shurety, F Newell, R McGeary, N Pelton, J Grant, A Herington, D Cameron, J Whitehead, J Prins |
Diabetes | 2004 |
Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review
ES Freedland |
Nutrition & Metabolism | 2004 |
Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus
L Heilbronn, SR Smith, E Ravussin |
International Journal of Obesity | 2004 |
Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach
H Bays, L Mandarino, RA DeFronzo |
The Journal of clinical endocrinology and metabolism | 2004 |
Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats
B Yang, KK Brown, L Chen, KM Carrick, LG Clifton, JA McNulty, DA Winegar, JC Strum, SA Stimpson, GL Pahel |
BMC pharmacology | 2004 |
Intramyocellular lipids and insulin resistance
J Machann, H Haring, F Schick, M Stumvoll |
Diabetes, Obesity and Metabolism | 2004 |
Subcutaneous Adipocytes Can Differentiate into Bone-Forming Cellsin Vitroandin Vivo
J Justesen, SB Pedersen, K Stenderup, M Kassem |
Tissue Engineering | 2004 |
Effects of food restriction on peroxisome proliferator-activated receptor-γ and glucocorticoid receptor signaling in adipose tissues of normal rats
K Arai, T Soga, H Ohata, A Otagiri, T Shibasaki |
Metabolism | 2004 |
METABOLIC IMPROVEMENT AND ABDOMINAL FAT REDISTRIBUTION IN WERNER SYNDROME BY PIOGLITAZONE
K Yokote, S Honjo, K Kobayashi, M Fujimoto, H Kawamura, S Mori, Y Saito |
Journal of the American Geriatrics Society | 2004 |
Differential effects of PD98059 and U0126 on osteogenesis and adipogenesis
ZC Dang, CW Lowik |
Journal of Cellular Biochemistry | 2004 |
Differential effects of peroxisome proliferator activated receptor-gamma (PPARgamma) ligands in proximal tubular cells: Thiazolidinediones are partial PPARgamma agonists
RS Chana, AJ Lewington, NJ Brunskill |
Kidney International | 2004 |
Induction of Adipocyte-Like Phenotype in Human Mesenchymal Stem Cells by Hypoxia
T Fink, L Abildtrup, K Fogd, BM Abdallah, M Kassem, P Ebbesen, V Zachar |
Stem Cells | 2004 |
No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial
A Carr, C Workman, D Carey, G Rogers, A Martin, D Baker, H Wand, M Law, K Samaras, S Emery, DA Cooper |
The Lancet | 2004 |
Thiazolidinediones
H Yki-Järvinen |
New England Journal of Medicine | 2004 |
Peroxisome proliferator-activated receptor γ: Its role in metabolic syndrome
R Pakala, P Kuchulakanti, SW Rha, E Cheneau, R Baffour, R Waksman |
Cardiovascular Radiation Medicine | 2004 |
A yeast two-hybrid technology-based system for the discovery of PPARγ agonist and antagonist
Q Chen, J Chen, T Sun, J Shen, X Shen, H Jiang |
Analytical Biochemistry | 2004 |
Computerized Determination of Adipocyte Size
T Björnheden, B Jakubowicz, M Levin, B Odén, S Edén, L Sjöström, M Lönn |
Obesity research | 2004 |
The Yellow Agouti Mutation Alters Some But Not All Responses to Diet and Exercise
S Chiu, JS Fisler, GM Espinal, PJ Havel, JS Stern, CH Warden |
Obesity research | 2004 |
The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo
Iwona Bogacka, Hui Xie, George A Bray, Steven R Smith |
Diabetes care | 2004 |
Lipids and glucose in type 2 diabetes: what is the cause and effect?
Guenther Boden, Markku Laakso |
Diabetes care | 2004 |
Development of multiple lipomas during treatment with rosiglitazone in a patient with HIV-associated lipoatrophy:
DD Mafong, GA Lee, S Yu, P Tien, T Mauro, C Grunfeld |
AIDS | 2004 |
Characterization of differentiated subcutaneous and visceral adipose tissue from children: the influences of TNF-α and IGF-I
M Grohmann, M Sabin, J Holly, J Shield, E Crowne, C Stewart |
Journal of lipid research | 2004 |
Expression of cellular inhibitor of apoptosis protein-2 in human subcutaneous and omental adipose tissue
X Li, R Chen, S Lindquist, O Hernell |
International Journal of Obesity | 2004 |
Combined Thiazolidinedione-Insulin Therapy: Should We Be Concerned About Safety?
AJ Scheen |
Drug Safety | 2004 |
Increased adipose tissue expression of Grb14 in several models of insulin resistance
B Cariou, N Capitaine, VL Marcis, N Vega, V Béréziat, M Kergoat, M Laville, J Girard, H Vidal, AF Burnol |
The FASEB Journal | 2004 |
Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy
SA Phillips, TP Ciaraldi, AP Kong, R Bandukwala, V Aroda, L Carter, S Baxi, SR Mudaliar, RR Henry |
Diabetes | 2003 |
International Textbook of Diabetes Mellitus
RA DeFronzo, L Mandarino, E Ferrannini |
International Textbook of Diabetes Mellitus | 2003 |
Do regional differences in adipocyte biology provide new pathophysiological insights?
M Lafontan, M Berlan |
Trends in Pharmacological Sciences | 2003 |
Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats
PD Hockings, KK Changani, N Saeed, DG Reid, J Birmingham, P O'Brien, J Osborne, CN Toseland, RE Buckingham |
Diabetes, Obesity and Metabolism | 2003 |
Thiazolidinediones – some recent developments
M Stumvoll |
Expert Opinion on Investigational Drugs | 2003 |
Is weight loss possible in patients treated with thiazolidinediones? Experience with a low-calorie diet
S Asnani, BC Richard, C Desouza, V Fonseca |
Current Medical Research and Opinion | 2003 |
c-Fos-driven transcriptional activation of transforming growth factor β-1: inhibition of high glucose-induced promoter activity by thiazolidinediones
C Weigert, K Brodbeck, A Bierhaus, HU Häring, ED Schleicher |
Biochemical and Biophysical Research Communications | 2003 |
Dexamethasone induced preadipocyte recruitment and expression of CCAAT/enhancing binding protein α and peroxisome proliferator activated receptor-γ proteins in porcine stromal-vascular (S-V) cell cultures obtained before and after the onset of fetal adipogenesis
GJ Hausman |
General and Comparative Endocrinology | 2003 |
Effects of rosiglitazone and linoleic acid on human preadipocyte differentiation
LJ Hutley, FM Newell, JM Joyner, SJ Suchting, AC Herington, DP Cameron, JB Prins |
European Journal of Clinical Investigation | 2003 |
Troglitazone but not rosiglitazone induces G1 cell cycle arrest and apoptosis in human and rat hepatoma cell lines
MA Bae, H Rhee, BJ Song |
Toxicology Letters | 2003 |
Apoptosis of human abdominal preadipocytes before and after differentiation into adipocytes in culture
D Papineau, AM Gagnon, A Sorisky |
Metabolism | 2003 |
Sex differences in the pharmacokinetics of pioglitazone in rats
Y Fujita, Y Yamada, M Kusama, T Yamauchi, J Kamon, T Kadowaki, T Iga |
Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology | 2003 |
Effect of rosiglitazone on spontaneous and clomiphene citrate–induced ovulation in women with polycystic ovary syndrome
G Ghazeeri, WH Kutteh, M Bryer-Ash, D Haas, RW Ke |
Fertility and Sterility | 2003 |
Pioglitazone Reduces Hepatic Fat Content and Augments Splanchnic Glucose Uptake in Patients With Type 2 Diabetes
M Bajaj, S Suraamornkul, T Pratipanawatr, LJ Hardies, W Pratipanawatr, L Glass, E Cersosimo, Y Miyazaki, RA DeFronzo |
Diabetes | 2003 |
Handbook of Obesity: Etiology and Pathophysiology, Second Edition
R Pasquali, V Vicennati, U Pagotto |
Handbook of Obesity: Etiology and Pathophysiology, Second Edition | 2003 |
Human Mesenchymal Stem Cells as an in Vitro Model for Human Adipogenesis
L Janderová, M McNeil, AN Murrell, RL Mynatt, SR Smith |
Obesity research | 2003 |
Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity
Samyah Shadid, Michael D Jensen |
Diabetes care | 2003 |
Effects of troglitazone in young first-degree relatives of patients with type 2 diabetes
Klaus Levin, Ole Hother-Nielsen, Jan Erik Henriksen, Henning Beck-Nielsen |
Diabetes care | 2003 |
PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?
TM Larsen, S Toubro, A Astrup |
International Journal of Obesity | 2003 |
Expression of the thermogenic nuclear hormone receptor coactivator PGC-1α is reduced in the adipose tissue of morbidly obese subjects
RK Semple, VC Crowley, CP Sewter, M Laudes, C Christodoulides, RV Considine, A Vidal-Puig, S O'Rahilly |
International Journal of Obesity | 2003 |
Greater replication and differentiation of preadipocytes in inherited corticosteroid-binding globulin deficiency
JM Joyner, LJ Hutley, AW Bachmann, DJ Torpy, JB Prins |
American journal of physiology. Endocrinology and metabolism | 2003 |
PPARα/γ ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly
JM Ye, MA Iglesias, DG Watson, B Ellis, L Wood, PB Jensen, RV Sørensen, PJ Larsen, GJ Cooney, K Wassermann, EW Kraegen |
American journal of physiology. Endocrinology and metabolism | 2003 |
Establishment of a human preadipose cell line, HPB-AML-I: Refractory to PPAR?-mediated adipogenic stimulation
I Torii, S Morikawa, A Nakano, K Morikawa |
Journal of Cellular Physiology | 2003 |
Body Habitus Changes Related to Lipodystrophy
F Sattler |
Clinical Infectious Diseases | 2003 |
CASE REPORT: Combined Treatment with Ursodeoxycholic Acid and Pioglitazone in a Patient with Nash Associated with Type 2 Diabetes and Psoriasis
S Itoh, A Kanazuka, T Akimoto |
Digestive Diseases and Sciences | 2003 |
Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes
T Tchkonia, N Giorgadze, T Pirtskhalava, Y Tchoukalova, I Karagiannides, RA Forse, M DePonte, M Stevenson, W Guo, J Han, G Waloga, TL Lash, MD Jensen, JL Kirkland |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2002 |
Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-gamma
M Arici, R Chana, A Lewington, J Brown, NJ Brunskill |
Journal of the American Society of Nephrology : JASN | 2002 |
Emerging paradigms for understanding fatness and diabetes risk
SR Smith, E Ravussin |
Current Diabetes Reports | 2002 |
Rosiglitazone: A Review of its Use in the Management of Type 2 Diabetes Mellitus
AJ Wagstaff, KL Goa |
Drugs | 2002 |
PPAR agonists in health and disease: a pathophysiologic and clinical overview
S Mudaliar, RR Henry |
Current Opinion in Endocrinology & Diabetes | 2002 |
Increased Fat Intake, Impaired Fat Oxidation, and Failure of Fat Cell Proliferation Result in Ectopic Fat Storage, Insulin Resistance, and Type 2 Diabetes Mellitus
E Ravussin, SR Smith |
Annals of the New York Academy of Sciences | 2002 |
Adipose depot-specific effects of PPARgamma agonists: a consequence of differential expression of PPARgamma in adipose tissue depots?
CT Montague |
Diabetes, Obesity and Metabolism | 2002 |
Stimulation of Peroxisome Proliferator-Activated Receptors α and γ Blocks HIV-1 Replication and TNFα Production in Acutely Infected Primary Blood Cells, Chronically Infected U1 Cells, and Alveolar Macrophages From HIV-Infected Subjects
PR Skolnik, MF Rabbi, JM Mathys, AS Greenberg |
JAIDS Journal of Acquired Immune Deficiency Syndromes | 2002 |
PPARgamma and the thiazolidinediones: molecular basis for a treatment of 'Syndrome X'?
C Sewter, A Vidal-Puig |
Diabetes, Obesity and Metabolism | 2002 |
The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity
FS Celi, AR Shuldiner |
Current Diabetes Reports | 2002 |
Thiazolidinediones in the treatment of Type 2 diabetes
AS Greenberg, AG Pittas |
Expert Opinion on Pharmacotherapy | 2002 |
The mode of action of thiazolidinediones
H Hauner |
Diabetes/Metabolism Research and Reviews | 2002 |
A treatment for Mr WP: thiazolidinediones after troglitazone
CT Montague |
Diabetic Medicine | 2002 |
Human B Lymphocytes and B Lymphomas Express PPAR-γ and Are Killed by PPAR-γ Agonists
J Padilla, E Leung, RP Phipps |
Clinical Immunology | 2002 |
Differentiating members of the thiazolidinedione class: a focus on safety
HE Lebovitz |
Diabetes/Metabolism Research and Reviews | 2002 |
Mesenchymal Cell Culture
AJ Katz |
2002 | |
New insights in the transcriptional activity and coregulator molecules in the arterial wall
F Nigris, LO Lerman, C Napoli |
International Journal of Cardiology | 2002 |
Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes
V Harmelen, A Dicker, M Rydén, H Hauner, F Lönnqvist, E Näslund, P Arner |
Diabetes | 2002 |
Effect of Rosiglitazone on Insulin Sensitivity and Body Composition in Type 2 Diabetic Patients: The online title of this article has been corrected and is different from the printed version
DG Carey, GJ Cowin, GJ Galloway, NP Jones, JC Richards, N Biswas, DM Doddrell |
Obesity research | 2002 |
Regulation of Glucose Transport and Insulin Signaling by Troglitazone or Metformin in Adipose Tissue of Type 2 Diabetic Subjects
TP Ciaraldi, AP Kong, NV Chu, DD Kim, S Baxi, M Loviscach, R Plodkowski, R Reitz, M Caulfield, S Mudaliar, RR Henry |
Diabetes | 2002 |
Rosiglitazone but Not Metformin Enhances Insulin- and Exercise-Stimulated Skeletal Muscle Glucose Uptake in Patients With Newly Diagnosed Type 2 Diabetes
K Hallsten, KA Virtanen, F Lonnqvist, H Sipila, A Oksanen, T Viljanen, T Ronnemaa, J Viikari, J Knuuti, P Nuutila |
Diabetes | 2002 |
The Peroxisome Proliferator-Activated Receptor- 2 Pro12Ala Polymorphism
M Stumvoll, H Haring |
Diabetes | 2002 |
Regional Differences in the Response of Human Pre-Adipocytes to PPAR and RXR Agonists
CP Sewter, F Blows, A Vidal-Puig, S O'Rahilly |
Diabetes | 2002 |
Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes
Yoshinori Miyazaki, Masafumi Matsuda, Ralph A DeFronzo |
Diabetes care | 2002 |
Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction
Harold E Lebovitz, Margaret Kreider, Martin I Freed |
Diabetes care | 2002 |
The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes
Adam B. Mayerson, Ripudaman S. Hundal, Sylvie Dufour, Vincent Lebon, Douglas Befroy, Gary W. Cline, Staffan Enocksson, Silvio E. Inzucchi, Gerald I. Shulman, Kitt F. Petersen |
Diabetes | 2002 |
Peroxisome Proliferator-activated Receptor γ (PPARγ) as a Molecular Target for the Soy Phytoestrogen Genistein
ZC Dang, V Audinot, SE Papapoulos, JA Boutin, CW Löwik |
The Journal of biological chemistry | 2002 |
Natural ligands of PPARγ:
O Nosjean, JA Boutin |
Cellular Signalling | 2002 |
Ligand activation of peroxisome proliferator-activated receptor γ induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity
N Yamakawa-Karakida, K Sugita, T Inukai, K Goi, M Nakamura, K Uno, H Sato, K Kagami, N Barker, S Nakazawa |
Cell Death and Differentiation | 2002 |
Angiotensin Blockade Prevents Type 2 Diabetes by Formation of Fat Cells
AM Sharma, J Janke, K Gorzelniak, S Engeli, FC Luft |
Hypertension | 2002 |
HIV Therapies and Atherosclerosis: Answers or Questions?
NR Madamanchi, C Patterson, MS Runge |
Arteriosclerosis, thrombosis, and vascular biology | 2002 |
Human Cell Culture
MR Koller, BO Palsson, JR Masters |
2002 | |
Effect of Pioglitazone on Abdominal Fat Distribution and Insulin Sensitivity in Type 2 Diabetic Patients
Y Miyazaki, A Mahankali, M Matsuda, S Mahankali, J Hardies, K Cusi, LJ Mandarino, RA DeFronzo |
The Journal of clinical endocrinology and metabolism | 2002 |
Thiazolidinediones and type 2 diabetes: new drugs for an old disease
TM O'MooreSullivan, JB Prins |
The Medical Journal of Australia | 2002 |
Differential Expression of Signal Transducers and Activators of Transcription during Human Adipogenesis
JB Harp, D Franklin, AA Vanderpuije, JM Gimble |
Biochemical and Biophysical Research Communications | 2001 |
The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance
M Caron, M Auclair, C Vigouroux, M Glorian, C Forest, J Capeau |
Diabetes | 2001 |
The biology of white adipocyte proliferation
DB Hausman, M DiGirolamo, TJ Bartness, GJ Hausman, RJ Martin |
Obesity Reviews | 2001 |
Different fat depots are distinct mini-organs
T Tchkonia, I Karagiannides, RA Forse, JL Kirkland |
Current Opinion in Endocrinology & Diabetes | 2001 |
Free fatty acids - do they play a central role in type 2 diabetes?
P Arner |
Diabetes, Obesity and Metabolism | 2001 |
Insulin-sensitizing action of rosiglitazone is enhanced by preventing hyperphagia
LC Pickavance, RE Buckingham, JP Wilding |
Diabetes, Obesity and Metabolism | 2001 |
Effects of Troglitazone on Cellular Differentiation, Insulin Signaling, and Glucose Metabolism in Cultured Human Skeletal Muscle Cells
C Kausch, J Krützfeldt, A Witke, A Rettig, O Bachmann, K Rett, S Matthaei, F Machicao, HU Häring, M Stumvoll |
Biochemical and Biophysical Research Communications | 2001 |
Rosiglitazone
BH Wolffenbuttel, JP Sels, MS Huijberts |
Expert Opinion on Pharmacotherapy | 2001 |
PPARγ agonists in type 2 diabetes: how far have we come in ‘preventing the inevitable’? A review of the metabolic effects of rosiglitazone
B Zinman |
Diabetes, Obesity and Metabolism | 2001 |
Anti-retroviral therapy, insulin resistance and lipodystrophy
SK Gan, K Samaras, A Carr, D Chisholm |
Diabetes, Obesity and Metabolism | 2001 |
Changes of Pyridine Nucleotide Levels during Adipocyte Differentiation of Mouse 3T3-L1 Cells
T FUKUWATARI, M DOI, E SUGIMOTO, T KAWADA, K SHIBATA |
Bioscience, Biotechnology, and Biochemistry | 2001 |
Therapeutic modulation of transcription factor activity
JG Emery, EH Ohlstein, M Jaye |
Trends in Pharmacological Sciences | 2001 |
A Review of Rosiglitazone in Type 2 Diabetes Mellitus
AL Werner, MT Travaglini |
Pharmacotherapy | 2001 |
Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance
CJ de Souza, M Eckhardt, K Gagen, M Dong, W Chen, D Laurent, BF Burkey |
Diabetes | 2001 |
Independent Influences of Central Fat and Skeletal Muscle Lipids on Insulin Sensitivity
SM Furler, AM Poynten, AD Kriketos, AJ Lowy, BA Ellis, EL Maclean, BG Courtenay, EW Kraegen, LV Campbell, DJ Chisholm |
Obesity research | 2001 |
Adipose depot-specific expression of cIAP2 in human preadipocytes and modulation of expression by serum factors and TNFα
CU Niesler, JB Prins, S O'Rahilly, K Siddle, CT Montague |
International Journal of Obesity | 2001 |
Improved Glycemic Control and Enhanced Insulin Sensitivity in Type 2 Diabetic Subjects Treated With Pioglitazone
Y Miyazaki, A Mahankali, M Matsuda, L Glass, S Mahankali, E Ferrannini, K Cusi, LJ Mandarino, RA DeFronzo |
Diabetes care | 2001 |
Resistin / Fizz3 Expression in Relation to Obesity and Peroxisome Proliferator-Activated Receptor- Action in Humans
DB Savage, CP Sewter, ES Klenk, DG Segal, A Vidal-Puig, RV Considine, S O'Rahilly |
Diabetes | 2001 |
Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders?: Challenges
A Cossarizza, C Mussini, A Viganò |
BioEssays | 2001 |
Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial
U Risérus, L Berglund, B Vessby |
International Journal of Obesity | 2001 |
Human adipose tissue endothelial cells promote preadipocyte proliferation
LJ Hutley, AC Herington, W Shurety, C Cheung, DA Vesey, DP Cameron, JB Prins |
American journal of physiology. Endocrinology and metabolism | 2001 |
Fat depot origin affects fatty acid handling in cultured rat and human preadipocytes
F Caserta, T Tchkonia, VN Civelek, M Prentki, NF Brown, JD McGarry, RA Forse, BE Corkey, JA Hamilton, JL Kirkland |
American journal of physiology. Endocrinology and metabolism | 2001 |
Magnitude of Peroxisome Proliferator-Activated Receptor-γ Activation is Associated With Important and Seemingly Opposite Biological Responses in Breast Cancer Cells:
CE Clay, AM Namen, G Atsumi, AJ Trimboli, AN Fonteh, KP High, FH Chilton |
Journal of Investigative Medicine | 2001 |
Estrogen Receptors in Human Preadipocytes
JM Joyner, LJ Hutley, DP Cameron |
Endocrine | 2001 |
MOLECULARREGULATION OFADIPOGENESIS
ED Rosen, BM Spiegelman |
Annual Review of Cell and Developmental Biology | 2000 |
Effects of Lipid-Related Factors on Adipocyte Differentiation of Bovine Stromal-Vascular Cells in Primary Culture
P WU, K SATO, F SUZUTA, Y HIKASA, K KAGOTA |
Journal of Veterinary Medical Science | 2000 |
Disorders of Glucose Metabolism in Patients Infected with Human Immunodeficiency Virus
MP Dubé |
Clinical Infectious Diseases | 2000 |
HIV Protease Inhibitor-Related Lipodystrophy Syndrome
A Carr |
Clinical Infectious Diseases | 2000 |
Human adipocyte proteomics - a complementary way of looking at fat
YD Halvorsen, WO Wilkison, MR Briggs |
Pharmacogenomics | 2000 |
HIV protease inhibitors block adipogenesis and increase lipolysis in vitro
JM Lenhard, ES Furfine, RG Jain, O Ittoop, LA Orband-Miller, SG Blanchard, MA Paulik, JE Weiel |
Antiviral Research | 2000 |
PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer
GJ Murphy, JC Holder |
Trends in Pharmacological Sciences | 2000 |
A Rational Approach to Drug Therapy of Type 2 Diabetes Mellitus
JM Chehade, AD Mooradian |
Drugs | 2000 |
PPAR-γ-Mediated Regulation of Normal and Malignant B Lineage Cells
J Padilla, K Kaur, SG Harris, RP Phipps |
Annals of the New York Academy of Sciences | 2000 |
Enhancing Effect of Troglitazone on Porcine Adipocyte Differentiation in Primary Culture: A Comparison with Dexamethasone
YD Tchoukalova, DB Hausman, RG Dean, GJ Hausman |
Obesity | 2000 |
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
BL Wajchenberg |
Endocrine reviews | 2000 |
Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and Zucker diabetic fatty rats and effects of rosiglitazone
XJ Cai, CA Lister, RE Buckingham, L Pickavance, J Wilding, JR Arch, S Wilson, G Williams |
Molecular Brain Research | 2000 |
Ritonavir increases the level of active ADD-1/SREBP-1 protein during adipogenesis:
AT Nguyen, AM Gagnon, JB Angel, A Sorisky |
AIDS | 2000 |
A Dominant-negative Peroxisome Proliferator-activated Receptor γ (PPARγ) Mutant Is a Constitutive Repressor and Inhibits PPARγ-mediated Adipogenesis
M Gurnell, JM Wentworth, M Agostini, M Adams, TN Collingwood, C Provenzano, PO Browne, O Rajanayagam, TP Burris, JW Schwabe, MA Lazar, VK Chatterjee |
The Journal of biological chemistry | 2000 |
Ligand type-specific Interactions of Peroxisome Proliferator-activated Receptor γ with Transcriptional Coactivators
Y Kodera, K Takeyama, A Murayama, M Suzawa, Y Masuhiro, S Kato |
The Journal of biological chemistry | 2000 |
Depot-related and thiazolidinedione-responsive expression of uncoupling protein 2 (UCP2) in human adipocytes
JE Digby, VE Crowley, CP Sewter, JP Whitehead, JB Prins, S O'Rahilly |
International Journal of Obesity | 2000 |
New Approaches to Drug Development
P Jollès |
2000 | |
Peroxisome Proliferator Activator Receptor-γ Agonists and 15-Deoxy-Δ 12,1412,14 -PGJ 2 Induce Apoptosis in Normal and Malignant B-Lineage Cells
J Padilla, K Kaur, HJ Cao, TJ Smith, RP Phipps |
Journal of immunology (Baltimore, Md. : 1950) | 2000 |
A Rational Approach to Drug Therapy of Type 2 Diabetes Mellitus:
JM Chehade, AD Mooradian |
Drugs | 2000 |
Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution
LC Pickavance, M Tadayyon, PS Widdowson, RE Buckingham, JP Wilding |
British Journal of Pharmacology | 1999 |
Current Views on the Mechanism of Action of Thiazolidinedione Insulin Sensitizers
BJ Goldstein |
Diabetes Technology & Therapeutics | 1999 |
Thiazolidinediones: a new class of antidiabetic drugs
C Day |
Diabetic Medicine | 1999 |
Effects of troglitazone on fat distribution in the treatment of male type 2 diabetes
T Kawai, I Takei, Y Oguma, N Ohashi, M Tokui, S Oguchi, F Katsukawa, H Hirose, A Shimada, K Watanabe, T Saruta |
Metabolism | 1999 |
Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study
J Patel, RJ Anderson, EB Rappaport |
Diabetes, Obesity and Metabolism | 1999 |
Troglitazone-Induced Heart and Adipose Tissue Cell Proliferation in Mice
MA Breider, AW Gough, JR Haskins, G Sobocinski, FA la Iglesia |
Toxicologic pathology | 1999 |
A Novel Method for Analysis of Nuclear Receptor Function at Natural Promoters: Peroxisome Proliferator-Activated Receptor γ Agonist Actions on aP2 Gene Expression Detected Using Branched DNA Messenger RNA Quantitation
TP Burris, PD Pelton, L Zhou, MC Osborne, E Cryan, KT Demarest |
Molecular Endocrinology | 1999 |
Emerging Approaches To The Tissue Engineering Of Fat
AJ Katz, R Llull, MH Hedrick, JW Futrell |
Clinics in Plastic Surgery | 1999 |
Type 2 Diabetes: An Overview
HE Lebovitz |
Clinical chemistry | 1999 |
Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men
Y Mori, H Kim-Motoyama, T Katakura, K Yasuda, H Kadowaki, BA Beamer, AR Shuldiner, Y Akanuma, Y Yazaki, T Kadowaki |
Biochemical and Biophysical Research Communications | 1998 |
Inhibition of 3T3-L1 Adipocyte Differentiation by Expression of Acyl-CoA-binding Protein Antisense RNA
S Mandrup, RV Sørensen, T Helledie, J Nøhr, T Baldursson, C Gram, J Knudsen, K Kristiansen |
The Journal of biological chemistry | 1998 |
Transcription-Modulating Drugs: A New Frontier in the Treatment of Essential Hypertension
TW Kurtz, DG Gardner |
Hypertension | 1998 |
Advances in Molecular and Cellular Endocrinology
MR Pollak, EM Brown |
Advances in Molecular and Cellular Endocrinology | 1997 |
Obesity and Diabetes
M Smith, R Levine |
Medical Clinics of North America | 1964 |